Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Other Non-Current Liabilities (2018 - 2026)

Kiniksa Pharmaceuticals International filings provide 7 years of Other Non-Current Liabilities readings, the most recent being $25.3 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 392.91% to $25.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $25.3 million, a 392.91% increase, with the full-year FY2025 number at $18.5 million, up 916.02% from a year prior.
  • Other Non-Current Liabilities hit $25.3 million in Q1 2026 for Kiniksa Pharmaceuticals International, up from $18.5 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $25.3 million in Q1 2026 to a low of $260000.0 in Q2 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $1.9 million (2023), compared with a mean of $5.4 million.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 77.21% in 2022 and later soared 916.02% in 2025.
  • Kiniksa Pharmaceuticals International's Other Non-Current Liabilities stood at $1.8 million in 2022, then rose by 1.03% to $1.9 million in 2023, then fell by 1.88% to $1.8 million in 2024, then soared by 916.02% to $18.5 million in 2025, then soared by 36.68% to $25.3 million in 2026.
  • The last three reported values for Other Non-Current Liabilities were $25.3 million (Q1 2026), $18.5 million (Q4 2025), and $14.5 million (Q3 2025) per Business Quant data.